chronic myelogenous leukemia
Showing NaN - NaN of 34
Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)
Not yet recruiting
- Chronic Myelogenous Leukemia
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Oct 12, 2023
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)
Recruiting
- Chronic Myelogenous Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Asciminib single agent
- +5 more
-
Ann Arbor, Michigan
- +49 more
Jan 26, 2023
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)
Recruiting
- CML
- +3 more
- Asciminib add-on
- +3 more
-
Augusta, Georgia
- +46 more
Jan 23, 2023
Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
-
Chicago, Illinois
- +87 more
Jan 20, 2023
Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +
Active, not recruiting
- Chronic Myelogenous Leukemia
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
- ABL001
- +3 more
-
Boston, Massachusetts
- +18 more
Jan 19, 2023
Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- iCaspase9-transduced T cells
- AP1903
-
Houston, Texas
- +1 more
Jul 22, 2022
Chronic Myelogenous Leukemia Patients Treated With Imatinib
Recruiting
- Chronic Myelogenous Leukemia
- Chart Review
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 8, 2022
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial
Completed
- Chronic Myelogenous Leukemia
- +3 more
-
Duarte, California
- +100 more
Jun 8, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Tetanus
-
Houston, Texas
- +1 more
Apr 20, 2020
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 5, 2020
Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Jan 13, 2020
Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),
Completed
- Acute Leukemia
- +8 more
- Tacrolimus (ARM with Methotrexate)
- +7 more
-
Duarte, California
- +29 more
Jan 2, 2019
Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelogenous Leukemia
- Lonafarnib (SCH66336)
- Imatinib Mesylate (Gleevec)
-
Houston, TexasM.D. Anderson Cancer Center
Nov 6, 2018
Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)
Completed
- Chronic Myelogenous Leukemia
- Hematologic Malignancies
-
San Francisco, California
- +4 more
May 15, 2018
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,
Terminated
- Myelodysplastic Syndrome
- +9 more
-
Phoenix, Arizona
- +6 more
Feb 13, 2018
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,
Completed
- Acute Lymphoblastic Leukemia
- +4 more
- ABT-348
- ABT-348 and azacitidine
-
Scottsdale, Arizona
- +2 more
Nov 16, 2017
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)
Terminated
- Acute Myelogenous Leukemia
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 16, 2016
Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston
Terminated
- Myelodysplastic and Myeloproliferative Disorders
- +7 more
- Campath
- +4 more
-
Houston, Texas
- +1 more
Mar 29, 2016
Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Fludarabine, Busulfan, NK cell infusion:)
Completed
- Leukemia
- Chronic Myelogenous Leukemia
- Fludarabine
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 4, 2016
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Houston (TH-302)
Completed
- Acute Myelogenous Leukemia
- +5 more
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
May 5, 2015
Chronic Myelogenous Leukemia Trial in Houston (Imatinib Mesylate (IM), TALL-104 cells)
Terminated
- Chronic Myelogenous Leukemia
- Imatinib Mesylate (IM)
- TALL-104 cells
-
Houston, TexasUT MD Anderson Cancer Center
May 29, 2014